Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuting Dai

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Acta Neuropathologica Communications|April 18, 2024
Therapeutic potential of targeting Nrf2 by panobinostat in pituitary neuroendocrine tumorsYijun Cheng, Yuting Dai, Hao Tang, et al.
Neuro-Oncology|July 11, 2024
Targeting HTR2B suppresses nonfunctioning pituitary adenoma growth and sensitizes cabergoline treatment via inhibiting Gαq/PLC/PKCγ/STAT3 axisShaojian Lin, Liangbo Wang, Changxi Han, et al.
Plant, Cell & Environment|December 6, 2021
A conserved clathrin-coated vesicle component, OsSCYL2, regulates plant innate immunity in riceYao Yao, Jihua Zhou, Can Cheng, et al.
Blood|February 27, 2026
CSNK1E Sustains Stem-like Drug Persistence in Diffuse Large B-cell LymphomaXiang Li, Mengke Liu, Qing Shi, et al.
ACS Nano|February 4, 2025
Voltage-Gated 90° Switching of Bulk Perpendicular Magnetic Anisotropy in FerrimagnetsZhengyu Xiao, Ruiwen Xie, Fernando Maccari, et al.
Frontiers of Medicine|December 26, 2025
Metabolic biomarkers for predicting onset and severity of CAR-T therapy-induced cytokine release syndrome in multiple myelomaXiaolin Ma, Tuantuan Gui, Shuangshuang Yang, et al.
Neuro-Oncology|February 26, 2022
TRIM65 determines the fate of a novel subtype of pituitary neuroendocrine tumors via ubiquitination and degradation of TPITHong Yao, Wanqun Xie, Yuting Dai, et al.
Journal for Immunotherapy of Cancer|July 21, 2022
Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilitiesJian Lin, Yuting Dai, Chen Sang, et al.
Science Translational Medicine|April 5, 2023
Diverse rescue potencies of p53 mutations to ATO are predetermined by intrinsic mutational propertiesHuaxin Song, Jiale Wu, Yigang Tang, et al.
Genome Medicine|April 24, 2024
Single-cell transcriptomics reveal distinct immune-infiltrating phenotypes and macrophage-tumor interaction axes among different lineages of pituitary neuroendocrine tumorsShaojian Lin, Yuting Dai, Changxi Han, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Acta Neuropathologica Communications|April 18, 2024
Therapeutic potential of targeting Nrf2 by panobinostat in pituitary neuroendocrine tumorsYijun Cheng, Yuting Dai, Hao Tang, et al.
Neuro-Oncology|July 11, 2024
Targeting HTR2B suppresses nonfunctioning pituitary adenoma growth and sensitizes cabergoline treatment via inhibiting Gαq/PLC/PKCγ/STAT3 axisShaojian Lin, Liangbo Wang, Changxi Han, et al.
Plant, Cell & Environment|December 6, 2021
A conserved clathrin-coated vesicle component, OsSCYL2, regulates plant innate immunity in riceYao Yao, Jihua Zhou, Can Cheng, et al.
Blood|February 27, 2026
CSNK1E Sustains Stem-like Drug Persistence in Diffuse Large B-cell LymphomaXiang Li, Mengke Liu, Qing Shi, et al.
ACS Nano|February 4, 2025
Voltage-Gated 90° Switching of Bulk Perpendicular Magnetic Anisotropy in FerrimagnetsZhengyu Xiao, Ruiwen Xie, Fernando Maccari, et al.
Frontiers of Medicine|December 26, 2025
Metabolic biomarkers for predicting onset and severity of CAR-T therapy-induced cytokine release syndrome in multiple myelomaXiaolin Ma, Tuantuan Gui, Shuangshuang Yang, et al.
Neuro-Oncology|February 26, 2022
TRIM65 determines the fate of a novel subtype of pituitary neuroendocrine tumors via ubiquitination and degradation of TPITHong Yao, Wanqun Xie, Yuting Dai, et al.
Journal for Immunotherapy of Cancer|July 21, 2022
Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilitiesJian Lin, Yuting Dai, Chen Sang, et al.
Science Translational Medicine|April 5, 2023
Diverse rescue potencies of p53 mutations to ATO are predetermined by intrinsic mutational propertiesHuaxin Song, Jiale Wu, Yigang Tang, et al.
Genome Medicine|April 24, 2024
Single-cell transcriptomics reveal distinct immune-infiltrating phenotypes and macrophage-tumor interaction axes among different lineages of pituitary neuroendocrine tumorsShaojian Lin, Yuting Dai, Changxi Han, et al.
Pageof 11